Bumetanide Oral Tablet 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Bumetanide: Oral tablet (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_9807.JPG
Bumetanide 0.5mg Tab
Sandoz Inc. a Novartis Company
Pill Identification: E 128 
Drug Image file DrugItem_9807.JPG
Bumetanide 0.5mg Tab
Sandoz Inc. a Novartis Company
Pill Identification: E 128 
Drug Image file default-drug-image.png
Bumetanide 0.5mg Tab
Drug Image file DrugItem_10229.JPG
Bumetanide 0.5mg Tab
Teva Pharmaceuticals USA
Pill Identification: Z 4232  |  0.5
Drug Image file DrugItem_19436.JPG
Bumetanide 0.5mg Tab
AvKARE, Inc.
Pill Identification: Z 4232  |  0.5

What is this Medicine?

BUMETANIDE (byoo MET a nide) is a diuretic. It helps you make more urine and to lose salt and excess water from your body. This medicine is used to treat high blood pressure, and edema or swelling from heart, kidney, or liver disease.

CVS Pharmacy Patient Statistics for Bumetanide: Oral tablet(0.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Bumetanide 0.5mg Tablet

NDC: 001850128
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Edema, Oliguria, Nephrotic Syndrome, Ascites, Heart Failure, Hypertension

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Bumetanide 0.5mg Tablet
Drug Image file DrugItem_20027.JPG
Sandoz Inc. a Novartis Company
Pill Identification: E 128 
Shape: round
Color: green
Drug Image file DrugItem_9807.JPG
Sandoz Inc. a Novartis Company
Pill Identification: E 128 
Shape: round
Color: green

Reported Side Effects for Bumetanide 0.5mg Tablet

High Triglycerides Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Deafness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Urination Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Cholesterol Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Impotence (erectile Dysfunction) Incidence:
0.1%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
0.1%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
0.2%*
Severity: MILD
Onset: RAPID
Protein In The Urine Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
0.4%*
Severity: MILD
Onset: RAPID
Kidney Failure Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Headache Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Brain Dysfunction Incidence:
0.6%*
Severity: MODERATE
Onset: DELAYED
Glycosuria Incidence:
0.7%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
0.8%*
Severity: MODERATE
Onset: RAPID
Postural Low Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Volume Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Low Calcium Levels Incidence:
2.4%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
4.5%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
6.6%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
9.2%*
Severity: MODERATE
Onset: DELAYED
Inceased Urination Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Low Kidney Function Incidence:
10.6%*
Severity: SEVERE
Onset: DELAYED
Low Potassium Levels Incidence:
14.7%*
Severity: MODERATE
Onset: DELAYED
Low Chloride Levels Incidence:
14.9%*
Severity: MODERATE
Onset: DELAYED
High Uric Acid Level Incidence:
18.4%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class 3 - Risk Documented in Animals

Second Trimester

Class 3 - Risk Documented in Animals

Third Trimester

Class 3 - Risk Documented in Animals

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Bumetanide

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.